Status:
RECRUITING
ASCENT Intervention for Brain Tumor Patients
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Malignant Brain Tumor
Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was develo...
Detailed Description
This study will examine the feasibility and acceptability of a novel, population-specific intervention designed to help patients with newly diagnosed malignant brain tumors cope with their illness. T...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Massachusetts General Hospital Cancer Center Patient
- Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
- English speaking
Exclusion
- Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
- Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale \< 8)
- Current or imminent hospice enrollment
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06099743
Start Date
May 15 2025
End Date
July 31 2029
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114